News | MRI Breast | February 10, 2017

Rapid Breast MRI Screening Improves Cancer Detection in Dense Breasts

New method cuts screening time to 7 minutes while increasing early detection rates

A new method for screening women with dense breast tissue may potentially save thousands of lives

February 10, 2017 — A new method for screening women with dense breast tissue may potentially save thousands of lives by detecting breast cancer four to six years earlier than mammographic technology.

Due to its cost, breast imaging using magnetic resonance imaging (MRI) is recommended only for women at high risk for cancer — an estimated 2 percent of women. Mammograms are the current standard for the rest of the population.

The new Rapid Breast MRI protocol — derived from original research by David A. Strahle, M.D., chairman of Regional Medical Imaging in Flint, Mich. — cuts scan time by 70 percent to only 7 minutes, significantly reducing costs and enabling its use for screening women with dense breasts. In conjunction with a local HMO, Strahle found that early detection would have major costs savings for both women and insurance companies when considering the 10 categories of expense dealing with breast cancer.

Read the article "From Aviation to Breast Imaging - Development of an Abbreviated Breast MRI Protocol"

Mammographic technology for women with dense breast tissue is simply not as effective as MRI in spotting cancer, Strahle noted. In addition, unlike tomosynthesis (3-D mammography) or mammograms, MRIs do not use X-ray radiation.

“It’s like trying to see a thunderstorm through clouds without radar,” Strahle said. “MRI sees through the dense tissue, allowing radiologists to spot virtually all suspicious tumors.”

The new MRI protocol allows screening of women on a regular basis who have dense breast tissue. Strahle conducted peer-reviewed research of 671 women over seven years, which was published on Jan. 30, 2017. The research also includes an easier method for radiologists to read the exams, greatly lowering the false positive rate to below that of any other breast screening method.

Although insurance providers do not yet cover Rapid Breast MRI, the exam costs $395 out-of-pocket at RMI, compared with a diagnostic MRI that runs $700 or more. In addition to reducing scan time, screening Rapid Breast MRI can potentially be conducted every other year, instead of yearly as with mammograms. This equates to an annual cost of only $198, less than the average breast screening costs of $252 in mid-Michigan, Strahle said.

Read the article "Breast MRI in Cancer Diagnosis"

Breast cancer continues to be a leading cause of death in women. About one in eight women will develop breast cancer in their lifetimes, with 85 percent of those cancers occurring in women with no family history, according to breastcancer.org.

The research was published Jan. 30 in the journal Breast Cancer Research and Treatment.

For more information: www.link.springer.com

Related Breast MRI Content

VIDEO: Developments in Breast Density Legislation and Screening Guidelines

VIDEO: What is New in Breast Imaging Technology

Screening MRI Detects BI-RADS 3 Breast Cancer in High-risk Patients

References

Strahle, D.A., Pathak, D.R., Sierra, A., Saha, S., et al. "Systematic development of an abbreviated protocol for screening breast magnetic resonance imaging," Breast Cancer Research and Treatment. Published online Jan. 30, 2017. DOI: 10.1007/s10549-017-4112-0

Related Content

Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly and Annual Meeting, the world’s largest annual radiology forum, to be held at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | July 21, 2021
July 21, 2021 — Registration is now open for the Radiological Society of North America (...
According to ARRS’ American Journal of Roentgenology (AJR), return to routine screening for BI-RADS 3 lesions on supplemental automated whole-breast US (ABUS) substantially reduces the recall rate, while being unlikely to result in adverse outcome

Normal right mediolateral oblique (A) and craniocarudal (B) view screening mammograms demonstrate density C breasts. Coronal (C), transverse (D), and reconstructed lateral (E) views from supplemental automatic breast ultrasound (ABUS) demonstrates 7 mm circumscribed slightly hypoechoic circumscribed lesion at 11 o’clock position in right breast. Lesion was classified as BI-RADS 3. Patient has undergone yearly mammograms for 4 years following the ABUS examination with no breast cancer diagnosis.

News | Breast Imaging | July 16, 2021
July 16, 2021 —...
Volpara now holds 98 granted patents across 27 countries
News | Breast Imaging | July 16, 2021
July 16, 2021 — Volpara has recently been granted another patent by the...
Interviews with the 1,000 at-risk patients also led to some interesting conclusions, Fine said. Even in the early days of 3D mammography, most women interviewed had at least heard about the technology.

Getty Images

News | Mammography | July 15, 2021
July 15, 2021 —  For any type of diagnostic test, technology that helps improve the reliability of test results is a
ujifilm's robust medical systems portfolio includes a comprehensive product lineup covering CT, MRI, fluoroscopy, digital radiography, women’s health, ultrasound, systems integration, endoscopy and endosurgery, enterprise imaging, assisted reproductive technology, cell culture media, cell therapy development, In-Vitro diagnostics (IVD), and investigational drug development
News | Radiology Imaging | July 14, 2021
July 14, 2021 — Fujifilm announced the launch of the ...
A new study set out to learn more about breast health for Black women and to establish a better understanding of the breast screening landscape by analyzing mammograms, screening intervals and interpretation performance for Asian, Black and white women across health systems throughout the United States, with participation from Advocate Health Care, Sanford Health and the University of Pennsylvania Health System.

Getty Images

Feature | Breast Imaging | July 06, 2021 | By Linda Goler Blount, MPH
Due to dangerous implications for years to come, facilities must increase efficiency and capacity for breast cancer care to recover from the impact of COVID-19

Getty Images

Feature | Breast Imaging | July 06, 2021 | By Ananth Ravi, Ph.D.
The challenges
Breast cancer recently surpassed lung cancer as the number 1 diagnosed cancer in the U.S., excluding nonmelanoma skin cancer. Additionally, the National Cancer Institute recently predicted an almost 10,000 excess deaths from breast and colorectal cancers over the next 10 years as a direct result of the pandemic, making it now more important than ever for women to take control over their breast health.
News | Artificial Intelligence | June 25, 2021
June 25, 2021 — Breast cancer recently ...
According to a new study, by the Harvey L. Neiman Health Policy Institute and the American College of Radiology’s National Mammography Database Committee, the most influential radiologist characteristics impacting mammography interpretive performance were geography, breast sub-specialization, performance of diagnostic mammography, and performance of diagnostic ultrasound.

Getty Images

News | Breast Imaging | June 23, 2021
June 23, 2021 — According to a new ...